Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Opioid overdose reversal drug likely safe for OTC use, says FDA

Opioid overdose reversal drug naloxone may be safe and effective for over-the-counter use in some forms, the U.S. Food and Drug Administration (FDA) said on Tuesday, potentially paving the way for its use federally.

Reuters

Several ministers in Rishi Sunak’s government have bullied civil servants, Whitehall union chief says

Claim comes amid allegations levelled against deputy PM Dominic Raab

The Independent UK

World making little progress on food waste, a big climate problem

Every Thursday, California resident Richard Redmond takes a gallon-sized container of food scraps to the farmers market in the city of South Pasadena where it is collected and composted for use in gardens – an effort to reduce the amount of household waste he sends to landfill.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

Deputy PM Raab ‘warned about his behaviour’ at the Foreign Office

Dominic Raab will stand in at Prime Minister’s Questions but is under pressure over allegations about his treatment of officials.

The Independent UK

Dominic Raab was warned about his behaviour by top Foreign Office official

Exclusive: fresh claims that Simon McDonald relayed staff complaints to Raab when he was foreign secretary

The Guardian - UK

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

Benzinga

Do Covid-19 tests expire? Here's the truth about the home kits

In January of this year, the FDA released a list of updated expiration dates for different at-home rapid Covid-19 tests.

Inverse

Read news from The Economist, FT, and more,
with one subscription

From science fiction to reality, 'no kill' meat may be coming soon

The meat of the future may be cultured directly from animal cells without slaughtering livestock. It's not yet sold in the U.S., but NPR got a tour of a leading start-up and a taste of their chicken.

WEKU

Cancer warning for dry shampoo products as new study finds alarming levels of benzene

A “known human carcinogen” has been found in a number of dry shampoo products, warns a new study

Daily Mirror

Listeria: Everything you need to know as deli meat outbreak kills at least one

Sixteen cases detected across six states, with almost half in New York, CDC warns

The Independent UK

Veru Stock Plummets 54% After FDA Advisors Vote Down Cancer-Turned-Covid Drug

Veru stock collapsed Thursday after the FDA's advisors voted against the company's cancer drug turned Covid treatment.

Investors Business Daily

Vaccine advocate, on science, truth, and why he’s not a fan of the latest COVID boosters

PHILADELPHIA -- Philadelphia’s most prominent immunization expert isn’t planning to get the latest COVID-19 booster shot, and doesn’t think most others need to either.

The Philadelphia Inquirer

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday

Gainers

Benzinga

Dow Surges 400 Points; Crude Oil Down 1%

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 400 points on Monday.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For Covid

Veru stock skyrocketed Monday after the Food and Drug Administration posted a mixed review of its repurposed cancer drug for Covid treatment.

Benzinga

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Benzinga

Dow Jumps Over 200 Points; Verve Therapeutics Shares Plummet

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Monday.

Benzinga

US Stocks Mixed; Dow Rises Over 50 Points

U.S. stocks traded mixed this morning, with the Dow Jones gaining over 50 points on Monday.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

1 Stock to Buy This Week Following Its Recent Earnings Beat

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

Investors Business Daily

Verve, Beam Stocks Crash After FDA Halts Plan To Test Gene Editor In People

U.S. officials halted Verve's plan to begin testing in people a gene-editing approach to high cholesterol, leading VERV stock to crash.

The Independent UK

High levels of cancer-causing chemical detected in dry shampoo, study finds

Benzene is a chemical which can raise the risk of some cancers after long-term exposure

StockNews.com

2 Stocks You Can Count on for Reliable Dividends

The Fed announced its fourth consecutive 75-bps rate hike this week. However, the Fed's aggression is expected to shrink eventually. Amid rampant market volatility, investor sentiment toward dividend stocks is robust. Therefore, fundamentally sound stocks Pfizer (PFE) and Caledonia Mining (CMCL) could be solid picks for a steady income stream.…

StockNews.com

Looking for Passive Income? Try This Monster Stock

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

The Independent UK

Death in CRISPR gene therapy study sparks search for answers

The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him

The Independent UK

Pfizer study says updated COVID boosters rev up protection

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

1 … 123 124 125 126

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

329 stories

Ministry of Justice

316 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.